España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Chemomab Therapeutics
CMMB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.66
0.00200
0.12%
Pre-Market: 7:55 PM EDT
Get Report
Comment
Chemomab Therapeutics (CMMB) Forecast
News
Earnings
Chemomab Therapeutics (CMMB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Chemomab Therapeutics (NASDAQ:CMMB) Stock
Chemomab Therapeutics Stock (NASDAQ: CMMB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
Oppenheimer Reiterates Outperform on Chemomab...
Benzinga Newsdesk
Thursday, November 14, 2024
Chemomab Therapeutics Q3 2024 GAAP EPS $(0.20...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Tuesday, October 15, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tuesday, September 03, 2024
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Wednesday, August 21, 2024
Chemomab Says Existing Liquidity Resources Of...
Benzinga Newsdesk
Chemomab Therapeutics Q2 2024 GAAP EPS $(0.01...
Benzinga Newsdesk
Friday, July 26, 2024
Chemomab Therapeutics Regains Compliance With...
Benzinga Newsdesk
Thursday, July 25, 2024
Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise
Vandana Singh
Chemomab Therapeutics Announces Private Place...
Benzinga Newsdesk
Chemomab Therapeutics Reported Topline Result...
Benzinga Newsdesk
Tuesday, June 25, 2024
CHEMOMAB Granted U.S. Patent #12018074: Anti ...
Benzinga Newsdesk
Thursday, June 06, 2024
Chemomab Therapeutics shares are trading lowe...
Benzinga Newsdesk
Chemomab Says It Presented Two Scientific Pos...
Benzinga Newsdesk
Monday, May 13, 2024
Maxim Group Initiates Coverage On Chemomab Th...
Benzinga Newsdesk
Thursday, May 09, 2024
Chemomab Therapeutics shares are trading high...
Benzinga Newsdesk
Chemomab Therapeutics Q1 2024 GAAP EPS $(0.28...
Benzinga Newsdesk
Wednesday, May 08, 2024
Chemomab Therapeutics Granted 180-Day Extensi...
Benzinga Newsdesk
Monday, May 06, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Chemomab Therapeutics shares are trading high...
Benzinga Newsdesk
Oppenheimer Upgrades Chemomab Therapeutics to...
Benzinga Newsdesk
Thursday, April 18, 2024
Chemomab Therapeutics shares are trading high...
Benzinga Newsdesk
Chemomab Reports New Peer-Reviewed Publicatio...
Benzinga Newsdesk
Monday, March 25, 2024
Chemomab shares are trading higher after the ...
Benzinga Newsdesk
Chemomab Bagged New European Patent for CM-10...
Benzinga Newsdesk
Friday, March 08, 2024
Oppenheimer Maintains Perform on Chemomab The...
Benzinga Newsdesk
Thursday, March 07, 2024
Cemomab Therapeutics shares are trading highe...
Benzinga Newsdesk
Chemomab Therapeutics Q4 EPS $(0.26) Up From ...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Thursday, February 22, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, February 21, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, February 20, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?
Vandana Singh
Chemomab Wins New Patents for CM-101, Its Fir...
Benzinga Newsdesk
Tuesday, January 30, 2024
Chemomab Therapeutics Announced Publication O...
Benzinga Newsdesk
Thursday, January 18, 2024
Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, January 03, 2024
Chemomab Announces Completion Of Patient Enro...
Benzinga Newsdesk
Tuesday, December 19, 2023
Roth MKM Reinstates Buy on Chemomab Therapeut...
Benzinga Newsdesk
Thursday, November 16, 2023
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Chemomab Therapeutics Reported On Its Poster ...
Benzinga Newsdesk
Wednesday, November 15, 2023
Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
Lisa Levin
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Chemomab Therapeutics shares are trading high...
Benzinga Newsdesk
US Stocks Gain; Producer Prices Fall In October
Lisa Levin
Why is Liver Disease Focused Chemomab Stock Trading Higher Today?
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Chemomab Therapeutics Receives FDA Fast Track...
Benzinga Newsdesk
Monday, November 13, 2023
Chemomab Presents New Clinical Data Supportin...
Benzinga Newsdesk
Thursday, November 09, 2023
Chemomab Therapeutics Q3 2023 Gaap EPS $(0.34...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch